Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice

Neuroscience Research

Volumn 63, Issue 1, 2009, Pages 72-75

  Muroyama, Akiko ^a   Inaka, Makiko ^a   Matsushima, Hiroaki ^a   Sugino, Haruhiko ^b   Marunaka, Yoshinori ^b   Mitsumoto, Yasuhide ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Dopamine; Emotional behavior; Magnesium depletion; Mouse model; MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; MAGNESIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DIET RESTRICTION; DOPAMINERGIC SYSTEM; MAGNESIUM DEFICIENCY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CAUSALITY; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EMOTIONS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MICE; MICE, INBRED C57BL; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA;

EID: 57649183826     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.09.009     Document Type: Article

References (24)

1. Bardgett M.E., Schultheis P.J., McGill D.L., Richmond R.E., and Wagge J.R. Magnesium deficiency impairs fear conditioning in mice. Brain Res. 1038 (2005) 100-106
2. Crawley J., and Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13 (1980) 167-170
3. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
4. Decollogne S., Tomas A., Lecerf C., Adamowicz E., and Seman M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol. Biochem. Behav. 58 (1997) 261-268
5. Fukae J., Mizuno Y., and Hattori N. Mitochondrial dysfunction in Parkinson's disease. Mitochondrion 7 (2007) 58-62
6. Hashimoto T., Nishi K., Nagasao J., Tsuji S., and Oyanagi K. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons. Brain Res. 1197 (2008) 143-151
7. Hashizume N., and Mori M. An analysis of hypermagnesemia and hypomagnesemia. Jpn. J. Med. 29 (1990) 368-372
8. Koenig J.H., and Ikeda K. Synaptic vesicles have two distinct recycling pathways. J. Cell Biol. 135 (1996) 797-808
9. Mori A., Ohashi S., Nakai M., Moriizumi T., and Mitsumoto Y. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Neurosci. Res. 51 (2005) 265-274
10. Mori H., Masaki H., Yamakura T., and Mishina M. Identification by mutagenesis of a Mg(2+)-block site of the NMDA receptor channel. Nature 358 (1992) 673-675
11. Murck H. Magnesium and affective disorders. Nutr. Neurosci. 5 (2002) 375-389
12. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22 (1999) 123-144
13. Oyanagi K., Kawakami E., Kikuchi-Horie K., Ohara K., Ogata K., Takahama S., Wada M., Kihira T., and Yasui M. Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathology 26 (2006) 115-128
14. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
15. Rasmussen H.H., Mortensen P.B., and Jensen I.W. Depression and magnesium deficiency. Int. J. Psychiatry Med. 19 (1989) 57-63
16. Schuurman A.G., van den Akker M., Ensinck K.T., Metsemakers J.F., Knottnerus J.A., Leentjens A.F., and Buntinx F. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 58 (2002) 1501-1504
17. Seelig M.S. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J. Am. Coll. Nutr. 13 (1994) 429-446
18. Singewald N., Sinner C., Hetzenauer A., Sartori S.B., and Murck H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract. Neuropharmacology 47 (2004) 1189-1197
19. Smith A.D., Castro S.L., and Zigmond M.J. Stress-induced Parkinson's disease: a working hypothesis. Physiol. Behav. 77 (2002) 527-531
20. Snyder A.M., Stricker E.M., and Zigmond M.J. Stress-induced neurological impairments in an animal model of parkinsonism. Ann. Neurol. 18 (1985) 544-551
21. Sobolevskii A.I., and Khodorov B.I. Blocker studies of the functional architecture of the NMDA receptor channel. Neurosci. Behav. Physiol. 32 (2002) 157-171
22. Topf J.M., and Murray P.T. Hypomagnesemia and hypermagnesemia. Rev. Endocr. Metab. Disord. 4 (2003) 195-206
23. Urakami K., Masaki N., Shimoda K., Nishikawa S., and Takahashi K. Increase of striatal dopamine turnover by stress in MPTP-treated mice. Clin. Neuropharmacol. 11 (1988) 360-368
24. Zigmond M.J., and Stricker E.M. Parkinson's disease: studies with an animal model. Life Sci. 35 (1984) 5-18